OmniComm Systems Inc (OMCM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OmniComm Systems Inc (OMCM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7067
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OmniComm Systems Inc (OmniComm) is a provider of electronic data capture and eClinical software and services. It provides web-based applications to pharmaceutical, biotech and medical device companies. The company’s solutions allow clinical trial sponsors and investigative sites to securely collect, validate, transmit and analyze clinical study data. OmniComm’s major product offerings include eClinical solutions for life including TrialMaster Suite, TrialOne Suite, eClinical Suite and Promasys. The company also offers a wide range of services to enhance clinical study execution including professional services, electronic data capture (EDC) services, training and data center. It operates in the US and Europe with subsidiaries in New Jersey, Germany, the Netherlands, Spain and the UK. OmniComm is headquartered in Fort Lauderdale, Florida, the US.

OmniComm Systems Inc (OMCM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OmniComm Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OmniComm Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OmniComm Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OmniComm Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OmniComm Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OmniComm Systems Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
OmniComm Systems Acquires Certain Assets of Algorics 11
OmniComm Systems Acquires IRT Technology from ClinQuest 12
Partnerships 13
Pharma Medica Research Enters Into Licensing Agreement With OmniComm Systems For TrialMaster 13
OmniComm Systems Enters into Agreement with a Medical Research University in US 14
OmniComm Systems Enters into Agreement for TrialMaster EDC 15
OmniComm Systems Enters into Agreement for its TrialMaster 16
Larix Enters Into Licensing Agreement With Omnicomm For eClinical Solutions 17
OmniComm Systems Inc – Key Competitors 18
OmniComm Systems Inc – Key Employees 19
OmniComm Systems Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 14, 2018: OmniComm Systems announces financial results for the quarter and year-to-date period ending June 30, 2018 21
Apr 03, 2018: OmniComm Systems Reports Financial Results for the Year Ended December 31, 2017 22
Aug 15, 2017: OmniComm Systems Reports Financial Results for the Quarter and Year-to-Date Period Ending June 30, 2017 23
Mar 30, 2017: OmniComm Systems Reports Financial Results for the Year Ended December 31, 2016. Record Revenue and Operating Income 24
Corporate Communications 25
Oct 27, 2017: Kim Rejndrup Joins OmniComm as Senior Vice President of Development 25
Mar 15, 2017: OmniComm’s Early Investor and Long-Term CEO, Cornelis Wit, to Pass Baton to COO/President Stephen Johnson on June 1, 2017 26
Other Significant Developments 27
Apr 20, 2018: Topstone Research Selects OmniComm’s TrialMaster EDC 27
Mar 19, 2018: CTI Clinical Trial & Consulting Services Announces Expanded Multi-Year Commitment to OmniComm’s TrialMaster EDC 28
Feb 28, 2018: OmniComm Systems Records Significant Growth in China 29
Dec 14, 2017: TFS Signs New Agreement With OmniComm to Use TrialMaster EDC to Build and Support Studies 30
Oct 19, 2017: Novum Selects OmniComm as Strategic EDC Partner 31
Oct 09, 2017: OmniComm Systems Signs TrialOne Contract With Beijing Hospital of the Ministry of Health 32
Aug 09, 2017: SRD Signs Agreement With OmniComm to Build and Support Two Studies With TrialMaster 33
Jul 07, 2017: Gustave Roussy Signs Five-Year Commitment for OmniComm’s TrialMaster EDC to Support Cancer Research 34
Jun 14, 2017: OmniComm Systems Wins $11.7 Million TrialOne Contract With Global Contract Research Organization 35
Apr 27, 2017: OmniComm Systems Signs Fifth TrialOne Contract in China in Four Months 36
Mar 13, 2017: OmniComm Systems and CHDR, a Prestigious Dutch Academic Early-Stage Clinical Site, Announce Collaboration for High-Technology Innovation in Clinical Development 37
Feb 22, 2017: Bio-Optronics and OmniComm Systems to Provide Top-Tier Cancer Research Institution With CTMS and EDC for Real-Time Data Access 38
Feb 08, 2017: OmniComm Systems Announces 45 Percent Contract Growth in Research Hospitals and Academic Medical Centers 39
Jan 31, 2017: OmniComm Systems and MediStat Expand Life Sciences Market Presence in Israel 40
Jan 17, 2017: OmniComm Systems Experiencing Rapid Adoption of TrialOne in China 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
OmniComm Systems Inc, Medical Equipment, Key Facts, 2017 2
OmniComm Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OmniComm Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OmniComm Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OmniComm Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OmniComm Systems Inc, Deals By Market, 2012 to YTD 2018 9
OmniComm Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OmniComm Systems Acquires Certain Assets of Algorics 11
OmniComm Systems Acquires IRT Technology from ClinQuest 12
Pharma Medica Research Enters Into Licensing Agreement With OmniComm Systems For TrialMaster 13
OmniComm Systems Enters into Agreement with a Medical Research University in US 14
OmniComm Systems Enters into Agreement for TrialMaster EDC 15
OmniComm Systems Enters into Agreement for its TrialMaster 16
Larix Enters Into Licensing Agreement With Omnicomm For eClinical Solutions 17
OmniComm Systems Inc, Key Competitors 18
OmniComm Systems Inc, Key Employees 19
OmniComm Systems Inc, Other Locations 20
OmniComm Systems Inc, Subsidiaries 20

List of Figures
OmniComm Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OmniComm Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OmniComm Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OmniComm Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OmniComm Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OmniComm Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OmniComm Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OmniComm Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[OmniComm Systems Inc (OMCM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Instrumentation Laboratory Company:企業の製品パイプライン分析2018
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • Elmet Technologies Inc:企業の戦略・SWOT・財務分析
    Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • The Clorox Company (CLX):企業の財務・戦略的SWOT分析
    The Clorox Company (CLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Blue Dolphin Energy Co (BDCO):企業の財務・戦略的SWOT分析
    Summary Blue Dolphin Energy Co (Blue Dolphin) operates as an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolph …
  • Damco International B.V.
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tivity Health Inc (TVTY):企業の財務・戦略的SWOT分析
    Tivity Health Inc (TVTY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Epsilon Energy Ltd (EPS):企業の財務・戦略的SWOT分析
    Summary Epsilon Energy Ltd (Epsilon) is an oil and gas company that provides exploration, exploitation and development of oil and gas reserves. The company provides projects such as Marcellus shale in northeast Pennsylvania, Bakken Shale and Midale Dolomite in Saskatchewan, among others. It operates …
  • ION Geophysical Corp (IO):企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sennebogen Maschinenfabrik GmbH:企業の戦略・SWOT・財務情報
    Sennebogen Maschinenfabrik GmbH - Strategy, SWOT and Corporate Finance Report Summary Sennebogen Maschinenfabrik GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • iTeos Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Cooper Tire & Rubber Co (CTB):企業の財務・戦略的SWOT分析
    Cooper Tire & Rubber Co (CTB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company's lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platfor …
  • MGM China Holdings Ltd:戦略・SWOT・企業財務分析
    MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary MGM China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆